I. Davis

发表

Effect of aprotinin on renal dysfunction

K. Zacharowski, R. Mouton, D. Finch, 2008, The Lancet.

Effect of aprotinin on renal dysfunction

K. Zacharowski, R. Mouton, D. Finch, 2008 .

Antimalarial Therapy Selection for Quinolone Resistance among Escherichia coli in the Absence of Quinolone Exposure, in Tropical South America

B. Willey, A. McGeer, N. Daneman, 2008, PloS one.

Successful Treatment of Severe Falciparum Malaria With Adjunctive Use of Exchange Transfusion

Naif R. Aljohani, I. Davis, 2013 .

Response to Alert on Possible Infections with Mycobacterium chimaera From Contaminated Heater-Cooler Devices in Hospitals Participating in the Canadian Nosocomial Infection Surveillance Program (CNISP)

L. Johnston, Bonita E. Lee, L. Pelude, 2018, Infection Control & Hospital Epidemiology.

The Importance of Continued Quality Improvement Efforts in Monitoring Hospital-Acquired Infection Rates: A Cardiac Surgery Experience.

L. Johnston, J. Légaré, V. Mocanu, 2015, The Annals of thoracic surgery.

The evolving epidemiology of Clostridium difficile infection in Canadian hospitals during a postepidemic period (2009–2015)

M. Taljaard, M. Mulvey, J. Langley, 2018, Canadian Medical Association Journal.

Use of an interferon-gamma based assay to assess bladder cancer patients treated with intravesical BCG and exposed to tuberculosis.

P. Kavsak, I. Davis, M. Silverman, 2007, Clinical biochemistry.

Prevalence of Candida auris in Canadian acute care hospitals among at-risk patients, 2018

T. Dingle, A. Bharat, L. Hoang, 2020, Antimicrobial Resistance & Infection Control.

Trends in Clostridioides difficile infection rates in Canadian hospitals during the coronavirus disease 2019 (COVID-19) pandemic

J. Langley, J. Comeau, Bonita E. Lee, 2022, Infection control and hospital epidemiology.

Characterization of Healthcare-Associated and Community-Associated Clostridioides difficile Infections among Adults, Canada, 2015–2019

J. Langley, J. Comeau, Bonita E. Lee, 2022, Emerging infectious diseases.

S131 CP101, an Investigational Orally Administered Microbiome Therapeutic, Increases Intestinal Microbiome Diversity and Prevents Recurrent C. difficile Infection: Results From a Randomized, Placebo-Controlled Trial

T. Borody, C. Kelly, D. Pardi, 2021, American Journal of Gastroenterology.

S144 CP101 Engraftment Drives Efficacy: Results From a Randomized, Placebo-Controlled Trial Evaluating CP101, an Investigational Orally Administered Microbiome Therapeutic for Prevention of Recurrent C. difficile Infection

T. Borody, C. Kelly, D. Pardi, 2021, American Journal of Gastroenterology.

S145 Week 24 Efficacy and Safety Data from PRISM3: A Randomized, Placebo-Controlled Trial Evaluating CP101, an Investigational Orally Administered Microbiome Therapeutic for the Prevention of Recurrent C. difficile Infection

T. Borody, C. Kelly, D. Pardi, 2021, American Journal of Gastroenterology.

A case of tuberculous meningitis

I. Davis, H. McFadgen, P. Bonnar, 2016 .

Periprosthetic Infection following Primary Hip and Knee Arthroplasty: The Impact of Limiting the Postoperative Surveillance Period

D. Gravel, L. Johnston, V. Roth, 2016, Infection Control & Hospital Epidemiology.

Association of Medical Microbiology and Infectious Disease Canada treatment practice guidelines for Clostridium difficile infection

P. Moayyedi, T. Louie, L. Valiquette, 2018, Official Journal of the Association of Medical Microbiology and Infectious Disease Canada.

Results from the Canadian Nosocomial Infection Surveillance Program for detection of carbapenemase-producing Acinetobacter spp. in Canadian hospitals, 2010–16

M. Mulvey, J. Langley, G. Taylor, 2018, The Journal of antimicrobial chemotherapy.

Success of self-administered home fecal transplantation for chronic Clostridium difficile infection.

D. Pillai, I. Davis, M. Silverman, 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

BRIEF COMMUNICATION Success of Self-Administered Home Fecal Transplantation for Chronic Clostridium difficile Infection

D. Pillai, I. Davis, M. Silverman, 2010 .

Epidemiology of Primary and Recurrent Healthcare-Associated and Community-Associated Pediatric Clostridioides difficile Infection in Canada, 2015–2020

J. Langley, L. Pelude, G. Evans, 2023, Journal of the Pediatric Infectious Diseases Society.